HomeLUMO • NASDAQ
add
Lumos Pharma Inc
Previous close
$3.84
Day range
$3.61 - $3.85
Year range
$1.37 - $4.55
Market cap
30.81M USD
Avg Volume
49.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 488.00K | -7.40% |
Operating expense | 8.31M | -18.28% |
Net income | -7.55M | 15.45% |
Net profit margin | -1.55K | 8.69% |
Earnings per share | -0.93 | 14.68% |
EBITDA | -7.82M | 18.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.80M | -66.96% |
Total assets | 21.36M | -62.12% |
Total liabilities | 11.08M | -12.84% |
Total equity | 10.28M | — |
Shares outstanding | 8.12M | — |
Price to book | 3.05 | — |
Return on assets | -79.13% | — |
Return on capital | -136.38% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.55M | 15.45% |
Cash from operations | -6.38M | 4.56% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -6.38M | -3.30% |
Free cash flow | -3.72M | -1.99% |
About
Founded
1999
Headquarters
Website
Employees
33